Results 221 to 230 of about 9,342,565 (376)

Intensive care unit admission in patients with hematological disease: incidence, outcome and prognostic factors

, 2001
J. Evison, Peter Rickenbacher, R Ritz, Aloïs Gratwohl, C. Haberthür, S Elsässer, Jakob Passweg   +6 more
openalex   +1 more source

Nucleotides as an Anti‐Aging Supplementation in Older Adults: A Randomized Controlled Trial (TALENTs study)

Advanced Science, EarlyView.
The TALENTs randomized controlled trial evaluates the potential of nucleotides supplementation as an anti‐aging intervention in older adults. After 19 weeks, nucleotides supplementation significantly reduces DNA methylation age, suggesting a delay in epigenetic aging, and improves insulin sensitivity without severe adverse events.
Shuyue Wang, Lixia Song, Rui Fan, Qianqian Chen, Ruisheng Fu, Mei You, Yuxiao Wu, Meng Cai, Yong Li, Meihong Xu   +9 more
wiley   +1 more source

The Bloody Crossroads: Interactions between Periodontitis and Hematologic Diseases. [PDF]

Int J Mol Sci
Łobacz M, Mertowska P, Mertowski S, Kozińska A, Kwaśniewski W, Kos M, Grywalska E, Rahnama-Hezavah M.   +7 more
europepmc   +1 more source

Preliminary Studies of Serum Acute-Phase Protein Concentrations in Hematologic and Neoplastic Diseases of the Dog [PDF]

, 2005
Fernando Tecles, E. Spiranelli, U. Bonfanti, J. M. Castro Cerón, Saverio Paltrinieri   +4 more
openalex   +1 more source

Advanced Pharmaceutical Nanotechnologies Applied for Chinese Herbal Medicines

Advanced Science, EarlyView.
This review offers a comprehensive overview of pharmaceutical nanotechnology strategies to address limitations associated with the complex material basis and relative mild therapeutic efficacy of Chinese herbal medicines, and summarizes the advantages of these strategies.
Jiameng Li, Ya‐Li Zhang, Tong Jin, Zhaokui Jin, Mengliang Zhu, Guangchao Qing, Jinchao Zhang, Zhisen Wang, Yan Mu, Jin Li, Qian Hua, Xing‐Jie Liang   +11 more
wiley   +1 more source

P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1

HemaSphere, 2023
Shiyu Deng, Jiawang Ou, Zihong Cai, Zicong Huang, Xiuli Xu, Bingqing Tang   +5 more
doaj   +1 more source

Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition). [PDF]

Front Pharmacol
Zhao B, Zhou X, Zheng P, Zhang B, Feng X, Chen J, Cai L, Chen Y, He L, Su J, Cheng S, Zeng Y, Li G, Ji B, Wu J, Feng W, Liu M, Jin Y, Liu T, Mo X, Wu J, Wu H, Zhang H, Zheng Z, Zheng Z, Sun J, Li Y, Guangdong Pharmaceutical Association, Hematology Group of Rare Disease Expert Committee of Guangdong Pharmaceutical Association.   +28 more
europepmc   +1 more source

Alexithymic Characteristics in Children With Refractory Hematological Diseases

, 2001
Isao Fukunishi, Toshihisa Tsuruta
openalex   +1 more source

Blood signals: from birth to disease and death

, 2014
Bowman, T., Flores-Figueroa, E., King, K., Kokkaliaris, K., Lessard, J., Trompouki, E., Will, B.   +6 more
core   +1 more source